The global precocious puberty treatment market is anticipated to attain an impressive valuation of US$ 1,716.43 million in 2023 and is projected to reach US$ 3,650.66 million by 2033, trailing a CAGR of 7.8% during the forecast period. The focus of key industry players on getting product approval from regulatory aut.